Renaissance Technologies’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$408K Sell
181,395
-20,600
-10% -$46.4K ﹤0.01% 2934
2025
Q1
$277K Sell
201,995
-4,200
-2% -$5.75K ﹤0.01% 2953
2024
Q4
$326K Buy
206,195
+2,900
+1% +$4.58K ﹤0.01% 3006
2024
Q3
$252K Sell
203,295
-13,298
-6% -$16.5K ﹤0.01% 3047
2024
Q2
$290K Sell
216,593
-35,424
-14% -$47.5K ﹤0.01% 2918
2024
Q1
$343K Sell
252,017
-118,486
-32% -$161K ﹤0.01% 3030
2023
Q4
$971K Sell
370,503
-33,904
-8% -$88.9K ﹤0.01% 2427
2023
Q3
$1.29M Buy
404,407
+118,912
+42% +$380K ﹤0.01% 2127
2023
Q2
$1.44M Sell
285,495
-45,600
-14% -$229K ﹤0.01% 2212
2023
Q1
$954K Sell
331,095
-37,100
-10% -$107K ﹤0.01% 2509
2022
Q4
$862K Sell
368,195
-59,900
-14% -$140K ﹤0.01% 2619
2022
Q3
$1.92M Sell
428,095
-113,888
-21% -$511K ﹤0.01% 2041
2022
Q2
$3.18M Buy
541,983
+29,977
+6% +$176K ﹤0.01% 1872
2022
Q1
$3.34M Buy
512,006
+28,211
+6% +$184K ﹤0.01% 1852
2021
Q4
$6.2M Sell
483,795
-100
-0% -$1.28K 0.01% 1384
2021
Q3
$6.7M Sell
483,895
-35,100
-7% -$486K 0.01% 1284
2021
Q2
$5.35M Buy
518,995
+5,200
+1% +$53.6K 0.01% 1595
2021
Q1
$4.96M Sell
513,795
-40,600
-7% -$392K 0.01% 1654
2020
Q4
$3.99M Sell
554,395
-5,400
-1% -$38.9K ﹤0.01% 1729
2020
Q3
$2.64M Sell
559,795
-22,400
-4% -$106K ﹤0.01% 1964
2020
Q2
$3.23M Sell
582,195
-55,400
-9% -$307K ﹤0.01% 1893
2020
Q1
$2.29M Buy
637,595
+14,700
+2% +$52.8K ﹤0.01% 1983
2019
Q4
$5.27M Sell
622,895
-29,905
-5% -$253K ﹤0.01% 1818
2019
Q3
$4.42M Sell
652,800
-13,800
-2% -$93.4K ﹤0.01% 1862
2019
Q2
$4.48M Sell
666,600
-9,507
-1% -$63.9K ﹤0.01% 1876
2019
Q1
$4.27M Buy
676,107
+56,182
+9% +$354K ﹤0.01% 1908
2018
Q4
$4.02M Buy
619,925
+70,225
+13% +$455K ﹤0.01% 1859
2018
Q3
$3.9M Buy
549,700
+216,700
+65% +$1.54M ﹤0.01% 1955
2018
Q2
$1.45M Buy
333,000
+1,600
+0.5% +$6.96K ﹤0.01% 2436
2018
Q1
$984K Sell
331,400
-4,800
-1% -$14.3K ﹤0.01% 2667
2017
Q4
$874K Buy
336,200
+2,900
+0.9% +$7.54K ﹤0.01% 2716
2017
Q3
$1.13M Buy
333,300
+9,600
+3% +$32.5K ﹤0.01% 2535
2017
Q2
$800K Buy
323,700
+17,900
+6% +$44.2K ﹤0.01% 2639
2017
Q1
$816K Sell
305,800
-25,000
-8% -$66.7K ﹤0.01% 2616
2016
Q4
$1.19M Buy
330,800
+82,400
+33% +$296K ﹤0.01% 2475
2016
Q3
$1.29M Buy
248,400
+98,800
+66% +$515K ﹤0.01% 2433
2016
Q2
$245K Buy
149,600
+22,600
+18% +$37K ﹤0.01% 2994
2016
Q1
$212K Buy
127,000
+34,700
+38% +$57.9K ﹤0.01% 3064
2015
Q4
$194K Buy
92,300
+32,900
+55% +$69.2K ﹤0.01% 3003
2015
Q3
$116K Buy
59,400
+22,000
+59% +$43K ﹤0.01% 2991
2015
Q2
$104K Buy
37,400
+23,200
+163% +$64.5K ﹤0.01% 3086
2015
Q1
$34K Buy
+14,200
New +$34K ﹤0.01% 3097
2014
Q1
Sell
-11,600
Closed -$25K 2805
2013
Q4
$25K Sell
11,600
-13,400
-54% -$28.9K ﹤0.01% 2808
2013
Q3
$71K Sell
25,000
-8,300
-25% -$23.6K ﹤0.01% 2721
2013
Q2
$98K Buy
+33,300
New +$98K ﹤0.01% 2628